Shares of CSL Limited (ASX:CSL) reached a new 52-week high during trading on Friday . The company traded as high as A$245.99 ($174.46) and last traded at A$244.54 ($173.43), with a volume of 692595 shares trading hands. The stock had previously closed at A$239.81 ($170.08).
The business’s 50-day moving average price is A$231.84 and its 200 day moving average price is A$212.69. The company has a quick ratio of 1.09, a current ratio of 2.53 and a debt-to-equity ratio of 88.79. The company has a market capitalization of $110.99 billion and a P/E ratio of 57.87.
The company also recently disclosed a Final dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, October 11th were given a $1.478 dividend. The ex-dividend date of this dividend was Tuesday, September 10th. This represents a dividend yield of 0.65%. CSL’s dividend payout ratio (DPR) is currently 68.86%.
About CSL (ASX:CSL)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders.
Recommended Story: Cost of Capital Explained
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.